DAmour Kevin 4/A
4/A · Brooklyn ImmunoTherapeutics, Inc. · Filed Mar 17, 2022
Insider Transaction Report
Form 4/AAmended
DAmour Kevin
See Remarks
Transactions
- Award
Stock Option (Right to buy)
2022-03-11+138,400→ 138,400 totalExercise: $1.93Exp: 2032-03-11→ Common Stock (138,400 underlying)
Footnotes (1)
- [F1]The options vest and become exercisable in 36 substantially equal monthly installments from the grant date.